Hrt Financial LP Novo Nordisk A S Transaction History

Hrt Financial LP

$20.6 Billion
Q3 2025

A detailed history of Hrt Financial LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Hrt Financial LP holds 241,036 shares of NVO stock, worth $11.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

241,036

Previous 151,706 58.88%

Holding current value

$11.7 Million

Previous $10.5 Million 27.75%

% of portfolio

0.06%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$45.38 - $71.7 $4.05 Million - $6.4 Million	89,330 Added 58.88%	241,036 $13.4 Million
Q2 2025 Aug 14, 2025	BUY	$58.08 - $81.05 $5.35 Million - $7.47 Million	92,142 Added 154.69%	151,706 $10.5 Million
Q1 2025 May 15, 2025	BUY	$69.3 - $90.95 $699,167 - $917,594	10,089 Added 20.39%	59,564 $4.14 Million
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $4.21 Million - $5.94 Million	49,475 New	49,475 $4.26 Million
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $246,124 - $290,395	-2,384 Closed	0 $0

Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $1.35 Million - $1.64 Million	-14,547 Reduced 85.92%	2,384 $264,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $1.78 Million - $2.17 Million	-18,538 Reduced 52.27%	16,931 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $2.99 Million - $3.78 Million	35,469 New	35,469 $3.41 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $2.42 Million - $3.03 Million	-35,695 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $1.58 Million - $1.79 Million	23,604 Added 195.22%	35,695 $2.41 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $772,493 - $892,315	12,091 New	12,091 $844,000
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $278,400 - $312,196	-5,950 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $275,842 - $313,148	5,950 New	5,950 $311,000

Others Institutions Holding NVO

# of Institutions

1,697

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account